Reassessing the Role of Ischemia Imaging: Insights from the ISCHEMIA Trial
Malek Nayfeh1, Mouaz H Al-Mallah1
1Houston Methodist DeBakey Heart & Vascular Center, Houston, TX USA.
Insights
Ischemia imaging is crucial for guiding revascularization in coronary artery disease (CAD). While the ISCHEMIA trial showed mixed results, observational data support nuclear imaging
Area of Science:
- Cardiology
- Medical Imaging
- Nuclear Medicine
Background:
- Ischemia imaging is vital for prognostication and guiding revascularization decisions in patients with coronary artery disease (CAD).
- The ISCHEMIA trial presented conflicting findings regarding survival benefits of revascularization in moderate to severe ischemia.
- Limitations of the ISCHEMIA trial include its design not supporting imaging modality comparisons and exclusion criteria affecting applicability to certain patient groups (e.g., prior CABG, ACS).
Purpose of the Study:
- To evaluate the role of ischemia imaging in guiding revascularization strategies for patients with known CAD.
- To reconcile the findings of the ISCHEMIA trial with evidence from observational imaging registries.
- To clarify the diagnostic accuracy and clinical utility of nuclear stress imaging modalities like SPECT and PET.
Main Methods:
- Review and analysis of results from the ISCHEMIA trial.
- Examination of data from observational imaging registries focusing on single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
- Assessment of the impact of revascularization on cardiac and non-cardiac mortality in patients with moderate to severe ischemia.
Main Results:
- The ISCHEMIA trial suggested no overall survival benefit from revascularization, but recent analysis indicated decreased cardiac mortality and increased non-cardiac mortality.
- Observational registries provide stronger evidence for the accuracy of SPECT and PET in guiding revascularization decisions.
- The ISCHEMIA trial's findings are applicable to patients with moderate to severe ischemia who meet its inclusion criteria.
Conclusions:
- Nuclear imaging remains important for prognostication and guiding revascularization in CAD, supported by observational data.
- Shared decision-making is crucial for patients meeting ISCHEMIA trial inclusion criteria to choose between invasive management or optimal medical therapy.
- Further research is needed to fully understand the comparative accuracy of different ischemia imaging modalities.
Abstract:
Ischemia imaging plays an important role in prognostication as well as guiding decision for revascularization with known CAD, as shown in multiple observational registries. However, results from the ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) presented conflicting results, hinting at no survival benefit after revascularization in patients with moderate to severe ischemia on nuclear imaging. More recent analysis from the trial did, however, show decrease in cardiac mortality and increase in non-cardiac mortality following early revascularization. However, the ISCHEMIA trial has several limitations; most importantly, the trial design does not support a comparison between imaging modalities. Additionally, results of the trial do not apply to patients with previous CABG or ACS as they are exclusion criteria, which affects the diagnostic accuracy of nuclear stress imaging. Observational imaging registries offer better evidence about the accuracy of single-photon emission computed tomography (SPECT) and positron emission tomography (PET) in guiding revascularization for patients with ischemia. Results from ISCHEMIA trial can be used to guide management of patients with severe to moderate ischemia, provided they meet inclusion criteria. For those who do, shared decision-making is important to decide between invasive management or optimal medical therapy only.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imaging Studies for Cardiovascular System IV: CMRI
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies VII: Vascular Imaging
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology


